On September 23, the food additive synthetic biology production line project of the biotechnology company undertaken by Sanxi Group successfully completed all installation and commissioning work and was delivered on schedule, which marked that the project has fully entered the production and operation stage.

It is reported that the total investment of the production line is about 60 million yuan, and it is equipped with 4 fully automatic precision fermentation production lines. These production lines are equipped with advanced automated separation and purification systems, which can monitor various key parameters in the production process in real time to ensure comprehensive, efficient and precise control of product quality. The successful delivery of this project not only demonstrates Sanxi Group's deep technical accumulation in the field of synthetic biology equipment manufacturing, but also reflects its efficient project management and delivery capabilities. In recent years, with the continuous development of technologies such as gene editing and artificial intelligence, synthetic biology has triggered a new wave of research.

Scientists have high hopes for this cutting-edge science. They hope to use this technology to improve human health, respond to food crises, alleviate global warming and other common problems faced by mankind. Driven by policy support and technological progress, the synthetic biology market has ushered in unprecedented development opportunities. Its application areas are wide, covering many key areas such as medicine, agriculture, energy, and environmental governance. In 2024, the global synthetic biology market will reach US$20.8 billion, and by 2030, the global synthetic biology market will grow to US$77.5 billion. This scale of growth not only reflects the huge market potential of synthetic biology, but also reflects the strong global demand for synthetic biology products. For enterprises, the introduction of synthetic biology aims to reduce dependence on natural resources, increase product added value, and enhance the stability and resilience of the supply chain. Especially in the field of plant extraction, the application of synthetic biology will effectively alleviate the risks brought by fluctuations in raw material supply and provide solid guarantees for the production of high-purity, low-cost rare ingredients.

"We firmly believe that with the continuous iteration of technology and the continuous expansion of application scenarios, food and beverage and agriculture will become the two core areas for the future development of synthetic biology technology." Jiang Dawei, chairman of Sanxi Group, said in an interview with the media, "These two areas not only have huge market demand, but are also closely linked to people's lives. They are the key to achieving a win-win situation of social value and economic benefits for synthetic biology technology." As a pioneer in the field of synthetic biology equipment manufacturing, Sanxi Group is well aware that the success of each project is an affirmation of innovation and trust in cooperation. Therefore, the group will continue to deepen exchanges and cooperation with the industry, provide more scientific and intelligent synthetic biology production line equipment manufacturing solutions for global customers, and contribute to promoting the transformation and implementation of achievements in the field of synthetic biology and industrial upgrading.

https://pharm.jgvogel.cn/c1451000.shtml